3 Things Healthcare Agencies Need to Understand About Digital Advertising

The rapidly evolving digital advertising landscape is forcing healthcare agencies to rethink their strategies for long-term success. Agencies should be connecting the dots from planning to activation to measurement and optimization, utilizing first-party data for identity and measurement in the wake of cookie deprecation, and identifying top talent to help accelerate the path forward to success.

With RFP season right around the corner, these steps are pivotal as they begin developing their strategies for 2023.

Healthcare Agencies Need to Invest in People for Long-Term Success

The technology landscape is evolving every single day. Healthcare agencies must ensure they have people on their teams who understand these developments and drive change. Though the insights and industry wisdom from veteran employees remain valuable, agencies should make investments – both in time and monetarily – to ensure that they have a healthy mix of people with varying experience levels, backgrounds, and talents that can contribute to creating a more dynamic agency.

Investing in talent and training existing employees, especially those closest to the business, presents numerous benefits. Additionally, healthcare agencies are benefiting by hiring outside the organization, gaining greater diversity of thought, especially around technology and data. It’s a balancing act, but an important one in order to ensure diverse perspectives at the table.

The Importance of Connecting the Dots to Design a Successful Campaign

When planning a digital advertising campaign, it’s crucial to take every step of the process into account. In order to design and execute more effective, holistic campaigns, media buyers must connect the dots at every juncture – from planning to activation, to measurement and optimization.

Of course, healthcare agency departments responsible for planning, analytics, buying, and more already use data to make decisions. However, they aren’t necessarily using the same platforms to collect and assess their data. For instance, the analytics department may uncover an important trend across campaigns. But if their peers handling buying decisions aren’t aware or don’t have access to that analysis, what good is it?

Healthcare agencies can connect these dots by limiting silos and encouraging coordination and alignment at every stage.

Something that can help connect these dots is utilizing data at all stages of the campaign to perform real-time analysis and optimization. Is the data indicating that the campaign is not on track to reach results? The agency then has the opportunity to shift the strategy or to better align with the desired outcomes. This is key for being more data-driven, efficient, and prepared for a cookieless future.

How First-Party Data and CTV Will Be Key to the Cookieless Transition

With Google removing third-party cookies in 2023, a big industry focus in 2022 will be identity resolution and how to be more holistic in approaches to identification. Finding innovative ways to harness privacy-compliant identity information to accurately track and measure audience engagement for campaigns is imperative. In addition, healthcare agencies would be wise to begin testing cookieless approaches and leaning into new, innovative methods of identification and measurement before this looming deadline makes its arrival.

For many, this means relying more on the use of first-party data, alternative methods of ID, as well as exploring channels that don’t rely on cookies – such as connected TV (CTV). Cookieless by design, CTV presents valuable opportunities related to identity resolution. The rapid shift to this channel over the past few years highlights the success of these methods.

A recent DeepIntent report revealed that CTV devices are currently present in 85% of households. Household IDs and automatic content recognition (ACR) data, which captures and interprets audio and video clips, provide a more comprehensive picture as to what content is being consumed on a given connected device. Sans cookies, these tools will continue to prove their value in measuring campaign success and gathering useful consumer data.

To learn more about how patients feel about pharma ads on CTV, click here to download our research report, Seeing TV Differently: Patient Views During the CTV Renaissance.

More Insights

Driving NBRx and Improving AQ with Outcomes
Blog Post
Driving NBRx and Improving AQ: How DeepIntent Outcomes Delivers for Pharma Advertisers
There are more than 20,000 prescription drugs approved for marketing by the Food and Drug Administration (FDA). And yet, they all have one big thing...
Read More
Innovating With Intent 2023- The state of convergent TV
Blog Post
The State of Convergent TV: 3 Takeaways from Our Innovating with Intent Event
In its true form, convergence refers to the shift from analog to digital, something that’s been happening for many years. By 2022, Leichtman Research Group...
Read More
Switching from linear TV to CTV
Blog Post
Three Considerations for Healthcare Marketers Switching from Linear TV to CTV
For decades, traditional or linear TV has dominated the budgets of pharma advertisers. To meet industry recommendations developed decades ago, which call for audience sizes...
Read More
Back to Top